AVIEW LCS vs TOMTEC-ARENA

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Coreline Soft
VS
by TOMTEC Imaging Systems GmbH

AI Verdict

AVIEW LCS is a specialized AI tool for automated lung nodule detection, lung cancer screening, and cardiopulmonary assessment specifically from low-dose CT scans. In contrast, TOMTEC-ARENA offers a broader, multimodality, and vendor-neutral platform for advanced medical image analysis, quantification, and reporting across various cardiology and radiology applications. While both provide AI-powered image analysis and integration, AVIEW LCS is tailored for specific CT-based pulmonary and cardiac assessments, whereas TOMTEC-ARENA focuses on flexible, comprehensive analysis across diverse imaging modalities.

Choose AVIEW LCS if…

Choose AVIEW LCS if your primary need is an AI-powered solution for comprehensive lung cancer screening and cardiopulmonary assessment specifically from low-dose CT scans. It excels in automated lung nodule detection, Lung-RADS classification, and simultaneous quantification of emphysema and coronary artery calcification, streamlining workflows for pulmonology and oncology specialists.

View AVIEW LCS →

Choose TOMTEC-ARENA if…

Choose TOMTEC-ARENA if you require a highly flexible, vendor-neutral platform for advanced medical image analysis, quantification, and reporting across multiple modalities in cardiology and radiology. Its strength lies in AI-based measurement automation, support for 2D, 3D, and 4D data, and web-based diagnostic workflows, making it ideal for institutions seeking broad integration and remote access capabilities.

View TOMTEC-ARENA →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AVIEW LCS TOMTEC-ARENA
Pricing Subscription or one-off payment Unknown
Deployment Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) On-premise
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

TOMTEC-ARENA

TOMTEC-ARENA emphasizes web-based, vendor-neutral workflows and multimodality analysis, offering broad accessibility and flexibility across diverse clinical settings. User testimonials frequently highlight its intuitive handling, automation, and efficiency in complex assessments, suggesting a highly user-friendly experience. While AVIEW LCS also offers automated workflows and integration, TOMTEC-ARENA's broader platform approach and web access provide a slight edge in adaptability.

Clinical Value

AVIEW LCS

AVIEW LCS demonstrates superior clinical value through extensive validation for its integrated, AI-powered detection and analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan. Studies show it can achieve a 100% detection rate for certain cancers in follow-up scans and a lower likelihood of misidentifying nodules compared to human radiologists, significantly enhancing diagnostic accuracy and efficiency. While TOMTEC-ARENA offers advanced quantification in cardiology, AVIEW LCS's specific, validated outcomes for multi-disease screening are more compelling.

Pricing & Value

TOMTEC-ARENA

TOMTEC-ARENA provides greater transparency regarding its pricing model, detailing options like concurrent user licenses, automated archiving, maintenance contracts, and 'small business' pricing models for private practices. This allows potential buyers to better understand the cost structure and flexibility available. AVIEW LCS, in contrast, only states 'contact for pricing,' offering no public insight into its licensing or value proposition.

Enterprise Readiness

AVIEW LCS

AVIEW LCS explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for enterprise adoption in healthcare environments. It also offers flexible deployment options including cloud, hybrid, and on-premise, with integration into PACS/RIS. TOMTEC-ARENA requires contacting the vendor for HIPAA and BAA details, which introduces uncertainty for large-scale deployments.

Innovation

TOMTEC-ARENA

TOMTEC-ARENA's innovation lies in its broad, multimodality, and vendor-neutral platform, offering web-based workflows (TOMTEC ZERO) for flexible and remote access to advanced image analysis across various imaging data types (2D, 3D, 4D). This architectural flexibility and wide applicability represent a significant innovation in streamlining diverse clinical workflows. AVIEW LCS is highly innovative in its specific 3-in-1 multi-disease assessment from a single low-dose CT scan, but TOMTEC-ARENA's platform approach offers broader technological advancement.

Support & Docs

TOMTEC-ARENA

TOMTEC-ARENA offers a comprehensive support structure, including premium service, maintenance contracts, structured training sessions, monthly webinars on clinical topics, and e-learning modules for self-study. It also provides various user manuals and quick guides. While AVIEW LCS mentions technical and support documentation, TOMTEC-ARENA's detailed and multi-faceted approach to ongoing user education and support appears more extensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AVIEW LCS TOMTEC-ARENA
Name AVIEW LCS TOMTEC-ARENA
Company Coreline Soft Co. TOMTEC Imaging Systems GmbH
Description AI-powered solution for the detection and analysis of lung nodules. The AVIEW LCS Plus platform provides integrated, fully automatic analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan, enhancing diagnostic accuracy and streamlining radiology workflows. AI-powered, multimodality, vendor-neutral software for advanced medical image analysis, quantification, and reporting, primarily for cardiology and radiology, with web-based workflows.
Key Features Automated lung nodule detection and analysis, Lung-RADS classification and reporting, Nodule volume quantification and 3D segmentation, Emphysema quantification (LAA index), Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass), Automated comparison of nodules in follow-up CT scans, Comprehensive, automated report generation, Integration with PACS/RIS and third-party platforms AI-based measurement automation and data analytics, Multimodality and vendor-neutral imaging and analysis, Web-based diagnostic workflows (TOMTEC ZERO), Advanced quantification for various medical specialties, Structured reporting capabilities, DICOM connectivity and PACS/EMR integration, Automated archiving and data management, Support for 2D, 3D, and 4D image data
Specialties Cardiology, Oncology, Pulmonology, Radiology Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring AVIEW LCS and TOMTEC-ARENA.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AVIEW LCS is an AI-powered solution specifically designed for the detection and analysis of lung nodules, COPD, and coronary artery calcification from low-dose CT scans, catering to specialties like pulmonology, oncology, cardiology, and radiology. TOMTEC-ARENA, in contrast, offers a broader, multimodality, and vendor-neutral platform for advanced medical image analysis, quantification, and reporting, primarily for cardiology and radiology, supporting 2D, 3D, and 4D image data.
AVIEW LCS provides automated lung nodule detection and analysis, Lung-RADS classification and reporting, nodule volume quantification, emphysema quantification (LAA index), and coronary artery calcification (CAC) scoring. TOMTEC-ARENA focuses on AI-based measurement automation and advanced quantification for various medical specialties, emphasizing its multimodality and vendor-neutral capabilities for diverse image data.
Both AVIEW LCS and TOMTEC-ARENA offer integration capabilities with existing systems. AVIEW LCS supports integration with PACS/RIS and third-party platforms. TOMTEC-ARENA provides DICOM connectivity and PACS/EMR integration.
TOMTEC-ARENA explicitly highlights its multimodality and vendor-neutral imaging and analysis capabilities, supporting 2D, 3D, and 4D image data. AVIEW LCS is focused on analysis from CT scans, specifically for lung cancer screening, COPD, and coronary artery calcification.
AI Tool Finder
AI-powered search. Results may not be comprehensive.